Dong Sung Bio Pharm.Co.,Ltd. (KRX:002210)

KRX:002210 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Aug 21, 2026	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
Market Capitalization	140,357	24,633	24,810	26,238	21,826	36,502
Market Cap Growth	503.96%	-0.71%	-5.45%	20.22%	-40.21%	54.87%
Enterprise Value	-	40,658	42,182	43,804	36,221	56,080
Last Close Price	1495.00	1371.34	1351.36	1359.95	1080.35	1914.43

Price Ratios

Fiscal Year	Current	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Aug 21, 2026	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
PE Ratio	15.52	14.48	-	46.16	5.97	13.74
PS Ratio	1.79	0.31	0.35	0.38	0.35	0.61
PB Ratio	2.33	0.41	0.42	0.39	0.32	0.79
P/TBV Ratio	2.38	0.42	0.43	0.39	0.33	0.79
P/FCF Ratio	-	-	8.74	-	-	30.36
P/OCF Ratio	-	-	6.73	-	-	12.51

EV Ratios

Fiscal Year	Current	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Aug 21, 2026	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
EV/Sales Ratio	-	0.52	0.59	0.64	0.58	0.93
EV/EBITDA Ratio	-	8.82	-	18.10	12.61	18.56
EV/EBIT Ratio	-	13.10	-	39.66	24.38	36.05
EV/FCF Ratio	-	-	14.87	-	-	46.65

Financial Efficiency

Fiscal Year	Current	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Aug 21, 2026	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
Debt / Equity Ratio	0.58	0.58	0.57	0.46	0.40	0.68
Debt / EBITDA Ratio	7.57	7.57	-	12.93	9.42	10.39
Debt / FCF Ratio	-	-	11.87	-	-	26.10
Net Debt / Equity Ratio	0.34	0.34	0.26	0.27	0.20	0.38
Net Debt / EBITDA Ratio	4.49	4.49	-9.73	7.65	4.68	5.85
Net Debt / FCF Ratio	-6.84	-6.84	5.48	-3.22	-17.19	14.71
Asset Turnover	0.62	0.62	0.56	0.54	0.55	0.60
Inventory Turnover	3.06	3.06	2.83	2.47	2.49	2.42
Quick Ratio	1.18	1.18	1.20	1.39	1.61	1.49
Current Ratio	1.47	1.47	1.45	1.74	2.02	1.81
Return on Equity (ROE)	2.85%	2.85%	-12.36%	0.84%	6.42%	6.04%
Return on Assets (ROA)	1.54%	1.54%	-1.52%	0.55%	0.81%	0.96%
Return on Invested Capital (ROIC)	3.84%	3.88%	-3.86%	1.11%	1.43%	1.87%
Return on Capital Employed (ROCE)	4.20%	4.20%	-4.20%	1.30%	1.70%	2.40%

Yields

Fiscal Year	Current	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Aug 21, 2026	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
Earnings Yield	1.21%	6.91%	-31.66%	2.17%	16.75%	7.28%
FCF Yield	-2.15%	-12.28%	11.44%	-21.89%	-3.58%	3.29%
Dividend Yield	-	-	-	2.21%	2.78%	1.57%
Payout Ratio	31.14%	31.14%	-	95.83%	14.90%	25.81%
Buyback Yield / Dilution	2.59%	1.98%	0.79%	-	-4.39%	11.41%
Total Shareholder Return	2.59%	1.98%	0.79%	2.21%	-1.61%	12.98%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2013

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error